The peptoid approach to finding blood biomarkers has been used previously for systemic lupus erythematosus28 and autism spectrum disorder.29 The antibody is of the IgG3 subtype, is 84% accurate for the identification of de novo PD, and is positively correlated with disease severity (UPDRS score). The gene discussed is IGHG3; the disease is autism spectrum disorder.